(4-(4-amino-6-hydroxy-7-methoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone; 1-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine; Terazosin EP Impurity G
Terazosin EP Impurity G is a fully characterized chemical compound used as a reference standard of API Terazosin. The standard offered is compliant with regulatory guidelines. Terazosin EP Impurity G is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 105356-89-6
Related products
Terazosin EP Impurity L HCl (Prazosin EP Impurity D HCl)
M.F.
M.W. 180.21 36.46
CAT# AR-T04407
CAS# 60548-09-6
N-Nitroso Terazosin EP Impurity C (N-Nitroso Terazosin USP Related Compound A (Free Form), N-Nitroso Doxazosin EP Impurity G, N-Nitroso Prazosin EP Impurity C)
M.F.
M.W. 318.34
CAT# AR-T04406
CAS# NA
